These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 12028606)
1. Nesiritide: review of clinical pharmacology and role in heart failure management. Cheng JW Heart Dis; 2002; 4(3):199-203. PubMed ID: 12028606 [TBL] [Abstract][Full Text] [Related]
2. Nesiritide: a review of its use in acute decompensated heart failure. Keating GM; Goa KL Drugs; 2003; 63(1):47-70. PubMed ID: 12487622 [TBL] [Abstract][Full Text] [Related]
3. Nesiritide: a novel approach for acute heart failure. Vichiendilokkul A; Tran A; Racine E Ann Pharmacother; 2003 Feb; 37(2):247-58. PubMed ID: 12549957 [TBL] [Abstract][Full Text] [Related]
4. Nesiritide for the treatment of decompensated heart failure. Wylie JV; Tsao L Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426 [TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure. Butler J; Emerman C; Peacock WF; Mathur VS; Young JB; Nephrol Dial Transplant; 2004 Feb; 19(2):391-9. PubMed ID: 14736964 [TBL] [Abstract][Full Text] [Related]
6. "BNP" for heart failure: role of nesiritide in cardiovascular therapeutics. Mills RM; Hobbs RE; Young JB Congest Heart Fail; 2002; 8(5):270-3. PubMed ID: 12368590 [TBL] [Abstract][Full Text] [Related]
7. Nesiritide for the treatment of congestive heart failure. Iyengar S; Feldman DS; Trupp R; Abraham WT Expert Opin Pharmacother; 2004 Apr; 5(4):901-7. PubMed ID: 15102572 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of nesiritide for the treatment of decompensated heart failure. Emerman CL Rev Cardiovasc Med; 2002; 3 Suppl 4():S28-34. PubMed ID: 12439428 [TBL] [Abstract][Full Text] [Related]
9. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure). Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790 [TBL] [Abstract][Full Text] [Related]
10. Molecular and physiological effects of nesiritide. Reichert S; Ignaszewski A Can J Cardiol; 2008 Jul; 24 Suppl B(Suppl B):15B-8B. PubMed ID: 18629383 [TBL] [Abstract][Full Text] [Related]
11. Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure. Yancy CW Drug Saf; 2007; 30(9):765-81. PubMed ID: 17722969 [TBL] [Abstract][Full Text] [Related]
14. Nesiritide: harmful or harmless? Dorsch MP; Rodgers JE Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657 [TBL] [Abstract][Full Text] [Related]
15. The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction. Owan TE; Chen HH; Frantz RP; Karon BL; Miller WL; Rodeheffer RJ; Hodge DO; Burnett JC; Redfield MM J Card Fail; 2008 May; 14(4):267-75. PubMed ID: 18474338 [TBL] [Abstract][Full Text] [Related]
16. Nesiritide for the treatment of decompensated heart failure. Colucci WS J Card Fail; 2001 Mar; 7(1):92-100. PubMed ID: 11264555 [TBL] [Abstract][Full Text] [Related]
17. Nesiritide: a new therapy for the treatment of heart failure. Maisel AS Cardiovasc Toxicol; 2003; 3(1):37-42. PubMed ID: 12668889 [TBL] [Abstract][Full Text] [Related]